Analysis of the behaviour of selected CCK(B)/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex

British Journal of Pharmacology

Volumn 126, Issue 6, 1999, Pages 1496-1503

  Harper, E A ^a   Griffin, E P ^a   Shankley, N P ^a   Black, J W ^a  

^a James Black Foundation   (United Kingdom)

Author keywords

CCK(B) gastrin receptor; Guinea pig pancreas; JB93182; Mouse cortex; Rat cortex

Indexed keywords

1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; 5 [[[[(3,5 DICARBOXYPHENYL)AMINO]CARBONYL] 2 PHENYLETHYLAMINO] CARBONYL] 6 [[(1 ADAMANTYLMETHYL) AMINO]CARBONYL]INDOLE; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; GASTRIN ANTAGONIST; GASTRIN RECEPTOR; PD 140376; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033042405     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702448     Document Type: Article

References (35)

1. BEINBORN, M., LEE, Y.-M., MCBRIDE, E.W., QUINN, S.M. & KOPIN, A.S. (1993). A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature, 362, 348-350.
2. B/gastrin receptor antagonists. Eur. J. Pharmacol., 262, 233-245.
3. β receptor antagonist. Br. J. Pharmacol., 116, 241P.
4. β/gastrin receptor mRNA in colonic cell lines, human colonic carcinomas and hepatic metastasis: study of co-expression with gastrin, somatostatin, cholecystokinin (CCK) and TGF α mRNA. Gastroenterol., 108, A952.
5. BÖHME, G.A., BERTRAND, P., GUYON, C., CAPET, M., PENDLEY, C., STUTZMANN. J.M.,. COBLE, A., DUBROEUCQ. M.-J., MARTIN, G. & BLANCHARD, J.C. (1994). The ureidoacetamides, a novel family of non-peptide CCK-B/gastrin antagonists. Ann. N.Y. Acad. Sci., 713, 118-120.
6. 50 of an enzymic reaction. Biochem. Pharmacol., 22, 3099-3108.
7. CLARKE. C.R., DAUM, P. & HUGHES, J. (1986). A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK8 and CCK4 cholecystokinin receptor binding site. J. Neurochem., 46, 1094-1101.
8. CORSI, M., DAL FORNO, G., VAN AMSTERDAM, F.TH., FERIANI, A., URSINI, A., RATTI, E., GAVIRACHI, G. & TRIST, D.G. (1995). The characterisation in functional assays of GV150013: a novel CCK- β receptor antagonist. Br. J. Pharmacol., 114, 91P.
9. DE LEAN, A., STADEL, J.M. & LEFOKOWITZ, R. (1980). A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem., 255, 7108-7117.
10. DIXON, W.J. (1992). BMDP Statistical Software. University of California Press.
11. 3H]-H]-SNF 8702. Mol. Pharmacol., 42, 1089-1095.
12. Α receptors. Eur. J. Pharmacol., 232, 13-19.
13. β/gastrin receptor antagonist (JB93182) in mouse and rat cerebral cortex and guinea-pig pancreas. Br. J. Pharmacol., 117, 287P.
14. HARPER, E.A., ROBERTS. S.P., SHANKLEY, N.P. & BLACK, J.W. (1996a). Analysis of variation in L-365,260 competition curves in radioligand binding assays. Br. J. Pharmacol., 118, 1717-1726.
15. β/gastrin receptors. Br. J. Pharmacol. 126, 1496-1504.
16. HORWELL, D.C., HUGHES, J., HUNTER, J.C., PRITCHARD, M.C., RICHARDSON, R., ROBERTS, E. & WOODRUFF, G.N. (1991). Rationally designed 'dipeptoid' analogues of CCK. α-methyltryptophan derivatives as highly selective and orally active gastrin and CCK-β antagonists with potent anxiolytic properties. J. Med. Chem., 34, 404-414.
17. HOWBERT, J.J., LOBB, K.L., BRITTON. T.C., MASON, N.R. & BRUNS, R.F. (1993). Diphenylpyrazolidinone and benzodiazepine cholecystokinin antagonists: a case of convergent evolution in medical chemistry. Bioorgan. Med. Chem. Lett., 3, 875-880.
18. HUGHES, J., BODEN, P.R., COSTALL, B., DOMENEY, A., KELLY, E., HORWELL, D.C., HUNTER, J.C., PINNOCK, R,D. & WOODRUFF. G.N. (1990). Development of a class of selective cholecystokinin type B receptor antagonists having a potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A., 87, 6728-6732.
19. β/gastrin receptor in guinea-pig cerebral cortex and gastric mucosa. Mol. Pharmacol., 43, 595-602.
20. ITO, M., IWATA, N., TANIGUCHI, T., MURAYAMA, T., CHICARA, K. & MATSUI, T. (1994). Functional characterisation of two cholecystokinin-β/gastrin receptor isoforms: A preferential splice donor site in the human receptor gene. Cell Growth Differentiation, 5, 1127- 1135.
21. KALINDJIAN, S.B., BODKIN, M.J., BUCK, I.M., DUNSTONE, D.J., LOW. C.M.R., MCDONALD, I.M., PETHER, M.J. & STEEL, K.I.M. (1994). A new class of non-peptide cholecystokinin-β/gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane. J. Med. Chem., 37, 3671-3674.
22. KALINDJIAN, S.B., BUCK, I.M., DAVIES, J.M.R., DUNSTONE, D.J., HUDSON, M.L., LOW, C.M.R., MCDONALD, I.M., PETHER, M.J., STEEL, K.I.M., TOZER, M.J. & VINTER, J.C. (1996). Non- peptide cholecystokinin-β/gastrin receptor antagonists based on bicyclic heteroaromatic skeletons. J. Med. Chem., 39, 1806 1815.
23. LAM, Y.K.T., BOGEN, D., CHANG, R.S., FAUST, K.A., HENSENS, O.D., ZINK, D.L., SCHWARTZ, C.D., ZITANG, L., GARRITY, G.M., GAGLIARDI, M.M., CURRIE, S.A. & WOODRUFF, H.B. (1990). Novel and potent gastrin and brain cholecystokinin antagonists from streptomyces olivaceus. Taxonomy, fermentation, isolation, chemical conversions, and physico-chemical and biochemical properties. J. Antibiotics, 44, 613-625.
24. LOTTI, V.L. & CHANG, R.S.L. (1989). A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-β) ligand: L-365,260. Eur. J. Pharmacol., 162, 273-280.
25. LOWE, J.A., HAGEMEAN, D.L., DROZDA, S.E., BRYCE, D.K., CRAWFORD, R.T., ZORN, S., MORRONE, J. & BORDNER, J. (1994). 5-Phenyl-3-ureidobenzapi-2-ones as cholecystokinin-β antagonists. J. Med. Chem., 237, 3789-3811.
26. NISHIDA, A., MIYATA, K., TSUTSUMI, R., YUKI, H., AKUZAWA, S., KOBAYASHI, A., KAMATO, T., ITO, H., YAMANO, M., KATUYAMA, Y., SATOH, M.. OHTA, M. & HONDA, K. (1994). Pharmacological profile of (R)-1-[2,3-dihydro-1-(2′-methyl-phenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-y1]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin- β receptor antagonist, in Vitro and in Vivo. J. Pharmacol. Exp. Ther., 269, 725-731.
27. PATEL, S., SMITH, A.J., CHAPMAN, K.L., FLETCHER, A.E., KEMP, J.A., MARSHALL, G.R., HARGREAVES, R.J., RYECROFT, W., IVERSEN, L.L., IVERSEN, S.D., BAKER, R., SHOWELL, G.A., BOURRAIN, S., NEDUVELIL, J.G., MATASSA, V.J. & FREEDMAN, S.B. (1994). Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-β/gastrin receptor antagonist with high affinity in vitro and high potency in vivo. Mol. Pharmacol., 46, 943-948.
28. PENDLEY, C.E., FITZPATRICK, L.R., CAPALINO, A.J., DAVIS, M.A., ESTERLINE, N.J., JAKUBOWSKA, A., BERTRAND, P., GUYON, C., DUBROEUCQ, M.-J. & MARTIN, G.E. (1995). RP73830, a gastrin/cholecystokinin-β receptor antagonist with potent anti-ulcer activity in the rat. J. Pharmacol. Expt. Ther., 273, 1015-1022.
29. PISEGNA, J.R., DE WEERTH, A., HUPPI, K. & WANK, S.A. (1992). Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localisation. Biochem. Biophys. Res. Common., 189, 295-303.
30. PRESTI, M.E. & GARDNER, J.D. (1993). Receptor antagonists for gastrointestinal peptides. Am. J. Physiol., 264, G399-G406.
31. β/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Br. J. Pharmacol., 118, 1779 1789.
32. β/gastrin receptor antagonist in isolated stomach preparations of the immature rat, mouse and guinea-pig. FASEB. J., A2199.
33. SHANKLEY, N.P., ROBERTS, S.P., WATT, G.F., KOTECHA, A., HULL, R. & BLACK, J.W. (1997). Analysis of the complex pharmacology expressed by the CCK-β/gastrin ligand PD134,308 on gastric assays. ASPET Pharmacol., 39, P65.
34. SONG, I., BROWN, D.R., WILTSHIRE, R.N., GANTZ, I., TRENT, J.M. & YAMADA, T. (1993). The human gastrin/cholecystokinin type β receptor gene: Alternative splice donor site in exon 4 generate two variant mRNAs. Proc. Natl. Acad. Sci. U.S.A., 90, 9085-9089.
35. WANK, S.A., PISEGNA, J.R. & POIROT, S.S. (1994). Functional significance of potential splice variants of the human cholecystokinin (CCK) β receptor. Gastroenterology, 106, A850.